How tech transfer works in a time of COVID-19

How tech transfer works in a time of COVID-19

NINE months ago, as the COVID-19 pandemic was unfolding, I sat down with colleagues and we brainstormed. The virus was moving quickly, how could we help developing and least developed countries accelerate access to quality lifesaving health technologies? We researched, we spoke to experts and we activated our networks – there was no time to lose.

At the same time Mario Sanchez, a Costa Rican pharmacist and entrepreneur, was boarding a plane, on a mission to try to buy medical-grade masks. But what he thought would be a simple transaction— turned out to be an odyssey that took him from Costa Rica to the U.S., Poland, Germany, and the Netherlands. For small-scale manufacturers and entrepreneurs, finding genuine, quality and affordable materials and technology to manufacture COVID-19 health products is not easy – in the first half of this year it was virtually impossible. Every step of the way Mario was met with obstacles: false leads, shoddy materials, unscrupulous dealers and an unwillingness to open and share technologies.

A few days before the borders closed, Mario returned to Costa Rica with no masks and a sobering realisation: His country was facing a dire shortage of the masks and other personal protective equipment (PPE) that health professionals would need to confront the pandemic. And the only way Costa Rica was going to have enough of these supplies was to start making them.
In many ways, Mario was well-placed to take on this challenge—he runs a drug-manufacturing company and even wrote his master’s thesis on medical shortages.

Despite this, Mario struggled to access the technology necessary to make the medical-grade masks that hospitals desperately needed.
Whilst Mario had been on the road, our project had come to life. The Tech Access Partnership was launched – connecting manufacturers, entrepreneurs and other technology seekers in developing countries with global innovators, universities and others who make their intellectual property and technologies available in order to serve the common good.

Within a few days we linked Mario with a Turkish company, MEMSIS, that had developed a membrane for use in medical-grade masks. We accompanied the two parties as they reached an agreement and navigated the regulatory process. This was a partnership that Mario could trust.

In a matter of months, Mario has designed and manufactured a mask that is suitable for medical use, received regulatory approval from the Costa Rican government and produced and tested prototypes. Once manufacturing ramps up Mario will supply masks to Costa Rica, as well as the rest of Central America and the Caribbean—a region home to nearly 90 million people. We worked with the developer and Mario to help him understand the regulations and assessments necessary for the mask to get national and international approval

Mario’s project is proof that we can meet global health challenges by matching civic-minded innovators with enterprising manufacturers in developing countries. At the Tech Access Partnership, we record requests and offers, vet technologies and draw on UN and external expertise to set up optimal matches for tech transfer. This ensures that partnerships have a better chance at making a lasting impact. We are in talks with other local partners in Lesotho and South Africa, and confident that collaborations like these have the potential to bolster nations’ health systems and their broader economies.

Despite these successes, there is still much to do. COVID-19 has not always behaved as expected. As the virus and needs of developing countries change and adapt, so must we.
Community masks are an effective and suitable choice for the public, yet medical grade masks are crucial for protecting health care workers. At least 7,000 healthcare workers globally have died from Covid-19. We will continue connecting socially-minded entrepreneurs like Mario Sanchez with the technology they need to stem this tide.

As the virus treatment has evolved, we have learned that our initial projection of the need for more ventilators has not materialized. What developing countries need is increased capacity to maintain and repair the ventilators they already have or adapt them for use by COVID-19 patients. We are engaging other actors to extend their support to countries and also call on countries that now have excess capacity of ventilators to consider partnering with us to make these available to countries that still lack adequate capacity. The Tech Access Partnership will also pivot to addressing these important needs in the medical device space: oxygen and pulse oximeters.

Many of the sickest coronavirus patients need supplemental oxygen in order to survive, yet too many people are denied this life saving treatment because they live in countries with oxygen shortages. We are encouraged to see that some pilot studies have been undertaken to help low-resource health systems increase their ability to manufacture oxygen. Scaling these efforts is now key and we believe technology transfer can play a leading role.

Pulse oximeters have also become a crucial tool to determine whether a Covid-19 patient’s blood oxygen levels have dropped into the danger zone. And yet, most of the pulse oximeters on the market today produce accurate readings only on lighter skin tones, leading to potentially dangerous medical errors for people with darker skin. This represents another clear instance where it will be essential to broker a transfer of technology between intellectual property holders and local manufacturers to produce pulse oximeters that are suited to the population that will use them.

Meanwhile, despite manufacturers’ recent commitments to make a certain number of rapid diagnostic tests available to Least Developed Countries, through the WHO led ACT – Accelerator, these donations are not enough to properly manage the pandemic long-term. They do not free developing countries of dependency on others to meet their health needs. Effective technology transfer can. We will continue to take a leading role in technology transfer that boosts the vital local production of tests. At the same time, we and our partners will continue to advocate to address the shortages of investments for developing these essential diagnostic capacities, especially in developing countries.

While we remain committed to helping countries meet their health challenges, there is also potential to apply technology transfer to address other pressing issues faced by least developed countries. One of these problems is medical waste. WHO estimate that globally 89 million medical masks, 76 million gloves and 1.6 million goggles are needed each month for COVID-19 response. The pandemic has produced mountains of discarded personal PPE, hampering efforts to contain the pandemic and also harming the environment.

The Tech Access Partnership is committed to the achievement of the Sustainable Development Goals and has begun to consider ways to address the PPE waste challenges, using environmentally friendly technology and circular economic practices that eliminate waste.
The current moment is fraught with uncertainty as the very systems that sustain life—from our health systems to our ecosystems — are under unprecedented stress. We must not be afraid to adapt and aim for the highest possible standards.

Mario Sanchez took a risk and it is paying off -because he found the right partner. Never has it been more important to have genuine and trustworthy partnerships in place. At the WISH global healthcare summit in Qatar two weeks ago we shared ideas on how technology transfer offers commercial and social optimism for the future. We are taking a collective and nimble effort to get lifesaving technology to those that need it and to build solid health systems that can tackle the greatest health challenges of our time.

l Joshua Setipa is the Managing Director of the UN Technology Bank for Least Developed Countries. The Tech Access Partnership is a joint collaboration between The UN Technology Bank, UNDP, UNCTAD and WHO

Previous FLR to rule on Roma Kings, Warriors dispute
Next The houses Kao Mine built

Warning: count(): Parameter must be an array or an object that implements Countable in /home/thepostc/public_html/wp-content/themes/trendyblog-theme/includes/single/post-tags-categories.php on line 7

About author

You might also like


NUL incubator ready for market

ROMA – THE National University of Lesotho (NUL)’s Robotic Egg Incubator, Pius the XII, is ready to hit the markets. That’s thanks to the innovation of Seforo Mohlalisi and Thabo


Marriages from hell

Rose Moremoholo MASERU WHEN Bokang Ralentsoe’s case was finally heard in the magistrate’s court last week, it was expected that the man who had abducted her and had admitted as


Coalition politics are bad for development

This could be the shortest opinion piece I’ve written for thepost thus far. I mistakenly forgot my computer charger behind when travelling to Lesotho last week and started typing with